The Full Wiki

Quetiapine: Quiz


Question 1:
What is the chemical name of Quetiapine (IUPAC)
6-amino- 2-- 3- quinazolin- 4-one

Question 2:
What is the molecular weight of Quetiapine?
383.5099 g/mol
230.672 g/mol
518.05 g/mol
416.511 g/mol

Question 3: Use of Quetiapine to minimize the symptoms of ________ withdrawal has been studied.

Question 4: AstraZeneca has submitted a New Drug Application for a sustained-release version of quetiapine in the United States, ________, and the European Union in the second half of 2006 for treatment of schizophrenia.
CanadaBelizeUnited KingdomBarbados

Question 5: The US patent, which was set to expire in 2011, received a pediatric exclusivity extension which pushed its expiration to March 26, 2012[2]; however, in ________ it has already expired.
BarbadosCanadaUnited StatesUnited Kingdom

Question 6: There is a risk of development of tardive dyskinesia, an incurable ________, with any prolonged or high dose use of quetiapine and some other neuroleptic drugs.
Human brainNeurological disorderAlzheimer's diseaseNervous system

Question 7: [3] In 2004, it received its second indication for the treatment of mania-associated ________.
Bipolar disorderMajor depressive disorderSchizoaffective disorderPsychosis

Question 8: Studies conducted on ________ have resulted in the formation of cataracts.
English FoxhoundBeagleDachshundBasset Hound

Question 9: Quetiapine is indicated for the treatment of schizophrenia, depressive episodes associated with bipolar disorder, acute manic episodes associated with bipolar I disorder (as either monotherapy or adjunct therapy to lithium or ________), and maintenance treatment of bipolar I disorder (as adjunct therapy to lithium or divalproex).
TiagabineGabapentinValproic acidPregabalin

Question 10: Quetiapine may be used as a substitute to addictive ________ or sleeping tablets such as zolpidem because it often induces similar sedative effects on the patient.
BenzodiazepinePropofolGABA reuptake inhibitorBarbexaclone

Got something to say? Make a comment.
Your name
Your email address